ReviewHead and neck pathology2025
Micrometastasis and Isolated Tumor Cells in Oral Squamous Cell Carcinoma: Refining Nodal Staging with Emerging Technologies.
Review in Head and neck pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Artificial Intelligence-Driven MRI for Cervical Nodal Metastasis Detection in Oral Squamous Cell Carcinoma: A Hierarchical Meta-Analysis of Diagnostic Accuracy.Head & neck · 2026Pooled it
- Survival outcomes in node-positive early oral squamous cell carcinoma following sentinel lymph node biopsy or elective neck dissection: methodological considerations and clinical implications.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026Article
- Keratin 1 and keratin 18 as immunohistochemical markers for distinguishing pulmonary metastases of oral squamous cell carcinoma from primary lung squamous cell carcinoma.Scientific reports · 2026Article
- Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma: Evolving Prognostic Markers, Molecular Insights, and Implications for Precision Staging.Diagnostics (Basel, Switzerland) · 2026Review
- Node deposit size index as morphometric marker of intranodal tumour burden in node-positive oral cancer: a hypothesis-generating cohort study.Frontiers in oncology · 2026Article
- Micrometastasis and ITCs in OSCC: Integrating AI, Radiomics, and Biomarkers for Clinically Useful Nodal Staging.Head and neck pathology · 2025Article
- Visualization of artificial intelligence applications in oral disease diagnosis: A bibliometric analysis.Digital healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeCervical lymph node metastasis significantly influence prognosis in oral squamous cell carcinoma (OSCC), guiding staging, treatment decisions, and overall survival. Sentinel lymph node biopsy (SLNB) offers a minimally invasive approach for early detection of subclinical nodal metastasis, including micrometastases (0.2-2 mm) and isolated tumor cells (ITCs, < 0.2 mm). Despite its success in melanoma and breast cancer, the clinical relevance of micrometastases and ITCs in OSCC remains incompletely defined. This narrative review explores the biological significance, diagnostic challenges, and emerging strategies for detecting micrometastasis and ITCs in OSCC, aiming to inform their potential role in refining staging systems and treatment algorithms.
methodsWe performed a comprehensive literature review of SLNB in OSCC, examining data on histopathological detection techniques, molecular markers, artificial intelligence (AI), and radiomics-based tools that enhance diagnostic sensitivity and specificity for occult metastases.
resultsWhile current guidelines in some countries endorse SLNB for early-stage OSCC, integration of micrometastasis and ITC data into staging remains inconsistent. Studies suggest that ITCs represent early metastatic events with variable prognostic significance. Advanced techniques such as step-serial sectioning, immunohistochemistry, and molecular diagnostics-including ctDNA, gene-expression profiling, and AI-assisted pathology-have shown promise in improving detection accuracy. However, robust prospective data are lacking, and a consensus on the management of minimal nodal disease is yet to be reached.
conclusionAccurate identification and interpretation of micrometastasis and ITCs in OSCC represent an evolving frontier in head and neck oncology. Future staging systems should incorporate these elements supported by standardized protocols and high-level evidence. The integration of AI, molecular diagnostics, and radiomics holds the potential to enhance risk stratification and personalize surgical decision-making, reducing overtreatment while ensuring oncologic safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.